• Make CIFIT My Homepage
 
Notice
CIFIT Info
Worldwide Eye-catching International Investment Promotion Exposition
Home Page >> News Center >> Invest in China

Jiangxi to Strongly Boost the Zero Profit Sales of Drugs

Xinhua Net          2010-3-12 11:03:00    

[SIZE: Big   Medium   Small]

Jiangxi recently issued the Interim Provisions for the Establishment of the Mechanism of Multi-Channel Compensation for Grass-Roots Medical and Health Institutions to adopt the mode of “multi-channel compensation” compensation to establish the multi-channel fund guarantee mechanism to boost the zero profit sales of basic drugs. The provincial finance this year allocated RMB180m fiscal capital for the compensation for the zero profit sales of basic drugs and commenced to explore the establishment of the mulit-aspect compensation mechanism of finance and medical insurance funds, mainly consisting of medical insurance compensation, risk compensation, incentive compensation, reward compensation, compensation for basic construction and pharmaceutical affairs compensation to make up for the shortage of fiscal capital compensation.


Related
· MOFCOM: China’s Services Outsourcing Industry Makes Great Achievement
· Wang Qishan: Accelerate Development of Services Outsourcing Industry
· Yang Jiechi and Chen Deming Attended the 21st Ministerial Meeting of APEC
· Commerce Minister: Should Launch and Implement 8 New Measures for China-Africa Cooperation Soon
· Wen Jiabao Attended the Opening Ceremony of the 7th Shanghai Expo International Forum and Delivered Speech
 
  Print     Close

|About Us | Advertise on Site | Contact Us |
Copyright 1997-2012. All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China International Fair for Investment & Trade (CIFIT). Without written authorization from CIFIT, such content shall not be republished or used in any form.
Note: Browsers with 1024*768 or higher resolution are suggested for this site.

Power by: Xiamen Zongheng Group Science & Technology Co., Ltd. Registration Number: Min ICP05000161